Sarona Lengana

Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.

S. Madhi, K. O'Brien, C. Whitney, 2017, The Lancet. Global health.

Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.

S. Madhi, K. O'Brien, C. Whitney, 2017, The Lancet. Global health.

Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008.

B. Eley, Y. Coovadia, A. von Gottberg, 2019, The Pediatric infectious disease journal.

Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.

K. O'Brien, C. Whitney, B. Eley, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Laboratory-acquired infections of Salmonella enterica serotype Typhi in South Africa: phenotypic and genotypic analysis of isolates

Philip Smith, S. Madhi, C. Whitney, 2017, BMC Infectious Diseases.

Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003–2013

S. Madhi, A. von Gottberg, K. Klugman, 2016, Emerging infectious diseases.

Declining incidence of invasive meningococcal disease in South Africa: 2003-2016.

P. Naicker, A. von Gottberg, A. Hoosen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.